Related Experiment Videos
[Chronic viral hepatitis: current diagnosis and therapy]
1Departement für Innere Medizin, Universitätsspital Zürich.
Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis
|April 27, 1993
Summary
Viral infections like hepatitis B, C, and D cause chronic liver disease. Early diagnosis and prevention are key to reducing severe outcomes such as liver cirrhosis and cancer.
Area of Science:
- Hepatology
- Virology
- Infectious Diseases
Context:
- Viral hepatitis B (HBV), hepatitis delta virus (HDV), and hepatitis C (HCV) are significant contributors to chronic liver disease.
- Accurate identification of causative viral agents is crucial for effective patient management and public health strategies.
Purpose:
- To review the diagnostic methods, therapeutic interventions, and preventive measures for viral hepatitis B, C, and D.
- To highlight the clinical relevance of identifying specific viral etiologies for epidemiologic and therapeutic planning.
Summary:
- Serological and molecular techniques enable specific identification of HBV, HDV, and HCV.
- Interferon-alfa therapy shows moderate response rates for chronic hepatitis B (30-40%) and C (20-30%), with controversial results for hepatitis D.
- Preventive strategies include HBV vaccination, reduced blood transfusions, and improved hygiene to mitigate disease progression.
Impact:
- Informed therapeutic modifications and improvements for chronic viral hepatitis management.
- Reduced morbidity and mortality associated with acute and chronic hepatitis, including liver cirrhosis and hepatocellular carcinoma.
- Emphasizes the importance of vaccination and public health measures in controlling viral hepatitis transmission.